Sign inJoin waitlistJoin the waitlist

GR

Gary Reiss

Physician · Touro Infirmary

Credentials: · · · ·

History

Touro Infirmary
2026–Present

Gastroenterology
2005–2008
Internal Medicine
2002–2005
Louisiana State University School of Medicine in New Orleans
1998–2002

Research

Review article: hepatitis vaccination in patients with chronic liver disease
Review · Alimentary Pharmacology & Therapeutics · 2004 · First of 2 authors · 93 citations
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study
Clinical Gastroenterology and Hepatology · 2025 · 83 citations
Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak
Review · Journal of the American Geriatrics Society · 2006 · First of 4 authors · 35 citations

SR
Sanjay Ramrakhiani
4 papers
EK
Emmet Keeffe
3 papers
DK
Diana Koin
1 paper
GN
Guy Neff
1 paper
JS
Joshua Sickel
1 paper
JF
Juan Frias
1 paper
KL
Kathryn Lucas
1 paper
KS
Klaus See-Tho
1 paper
Pamela Kunz
1 paper
RG
Ramesh Gopi
1 paper
RC
Rebecca Clark
1 paper
SH
Stephen Harrison
1 paper

Clinical trials

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Site PI · Recruiting · Phase 3
Ardelyx
2026–2027
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Site PI · Recruiting · Phase 3
GlaxoSmithKline
2025–2028
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Site PI · Recruiting · Phase 3
GlaxoSmithKline
2025–2031
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032